US$ 28.04
blindness from glp 1 GLP-1 meds and vision: what the scary headlines DON'T say A nurse lost her eyesight
Description
How to diagnose sarcopenic obesity in candidates for bariatric surgery
26 It is also feasible that reduction in AMD risk factors such as obesity, cardiovascular disease, and hyperlipidemia with GLP-1RAs could further provide benefit by reducing systemic inflammation and vascular risk factors

This helps WeightWatchers determine if GLP-1 treatment might be right for you

Lancet Diabetes Endocrinol 2022;10:393-406.ArticlePubMed 134
